Posts

KOL Views Q&A: Prostate cancer at ASCO 2026—detailed looks at upstream data for J&J's Erleada, Pfizer's Talzenna

on

Abivax stock falls on cancer cases despite strong ulcerative colitis phase 3 data

on

ASCO 2026: J&J shows Erleada can break prostate cancer treatment mold in high‑risk localized disease

on

J&J's Erleada shows early wins in early prostate cancer but raises big questions for clinicians

on

Full-Life Technologies Raises $150M to Accelerate Clinical Assets and Manufacturing

on

Candel Therapeutics reports strong long‑term prostate cancer data ahead of FDA filing

on

FDA's Oncologic Drugs Advisory Committee to Review AstraZeneca's Cancer Drugs in First Meeting in 9 Months

on

Astellas and Vir Biotechnology Announce $1.7B Collaboration for VIR-5500 Prostate Cancer Drug, Including $240M Cash Upfront

on

Thousands Could Benefit from New Take-at-Home Treatment for Advanced Prostate Cancer

on

Thousands Could Benefit from New Take-at-Home Treatment for Advanced Prostate Cancer

on

Parabilis raises $305M to advance Helicon peptide cancer drugs against ‘undruggable’ targets

on

EDAP Receives FDA 510(k) Clearance for Advanced Focal One Robotic HIFU System Enhancements

on

Johnson & Johnson Acquires Halda Therapeutics for $3.05 Billion to Add RIPTAC Cancer Drug Platform

on

Candel Therapeutics Showcases Immunotherapy Leadership at SITC 2025, Highlighting Integration of Clinical Innovation, Multi-Omics, and AI for Solid Tumor Therapies

on

AstraZeneca and SOPHiA GENETICS Expand AI-Powered Cancer Testing Collaboration

on

Pfizer, Astellas' Xtandi Combo Extends Survival in Early Prostate Cancer

on

J&J's Akeega Advances PARP Inhibition in Prostate Cancer, but FDA Pathway in Broader Patient Subsets Remains Unclear

on

J&J Presents First Survival Data for KLK2-Targeted Bispecific Pasritamig in Prostate Cancer at ASCO 2025

on

FDA Advisory Committee Unanimously Votes Against Expanding Pfizer's Prostate Cancer Drug Combo

on

MacroGenics Discontinues Development of Vobra Duo ADC After Phase 2 Prostate Cancer Trial Results

on